{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:39:36Z","timestamp":1792694376556,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Young Leader Talent Training Program of Guangxi Medical University","award":["No. 202302"],"award-info":[{"award-number":["No. 202302"]}]},{"name":"Advanced Innovation Teams and Xinghu Scholars Program of Guangxi Medical University","award":["2023GXNSFAA026293"],"award-info":[{"award-number":["2023GXNSFAA026293"]}]},{"name":"NHC Key Laboratory of Thalassemia Medicine and Guangxi Key Laboratory of Thalassemia Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07251-2","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:06:38Z","timestamp":1787630798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional brain iron deposition and functional alterations in thalassemia: a multimodal human study with murine validation"],"prefix":"10.1007","volume":"105","author":[{"given":"Jingxuan","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongrong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"13","key":"7251_CR1","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","volume":"118","author":"EA Rachmilewitz","year":"2011","unstructured":"Rachmilewitz EA, Giardina PJ (2011) How I treat thalassemia. Blood 118(13):3479\u20133488","journal-title":"Blood"},{"issue":"20","key":"7251_CR2","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMra1404415","volume":"371","author":"FB Piel","year":"2014","unstructured":"Piel FB, Weatherall DJ (2014) The \u03b1-thalassemias. N Engl J Med 371(20):1908\u20131916","journal-title":"N Engl J Med"},{"issue":"1","key":"7251_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.15078","volume":"1530","author":"JC Wood","year":"2023","unstructured":"Wood JC (2023) Cardiac complications in thalassemia throughout the lifespan: Victories and challenges. Ann N Y Acad Sci 1530(1):64\u201373","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"7251_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s42000-023-00515-w","volume":"23","author":"TM Venou","year":"2024","unstructured":"Venou TM, Barmpageorgopoulou F, Peppa M, Vlachaki E (2024) Endocrinopathies in beta thalassemia: a narrative review. Horm (Athens) 23(2):205\u2013216","journal-title":"Horm (Athens)"},{"issue":"6","key":"7251_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/gim.2016.173","volume":"19","author":"R Origa","year":"2017","unstructured":"Origa R (2017) \u03b2-Thalassemia. Genet Med 19(6):609\u2013619","journal-title":"Genet Med"},{"issue":"8","key":"7251_CR6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00277-015-2378-z","volume":"94","author":"P Nemtsas","year":"2015","unstructured":"Nemtsas P, Arnaoutoglou M, Perifanis V, Koutsouraki E, Orologas A (2015) Neurological complications of beta-thalassemia. Ann Hematol 94(8):1261\u20135","journal-title":"Ann Hematol"},{"key":"7251_CR7","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2022.221111","author":"S Haghpanah","year":"2023","unstructured":"Haghpanah S, Hosseini-Bensenjan M, Sayadi M et al (2023) Risk factors for the occurrence of asymptomatic brain lesions in patients with \u03b2-thalassemia: a systematic review and meta-analysis. Clin Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2022.221111","journal-title":"Clin Lab"},{"issue":"1","key":"7251_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13023-024-03194-x","volume":"19","author":"R Manara","year":"2024","unstructured":"Manara R, Ponticorvo S, Contieri M et al (2024) Brain perfusion changes in beta-thalassemia. Orphanet J Rare Dis 19(1):212","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"7251_CR9","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00277-012-1527-x","volume":"91","author":"M Karimi","year":"2012","unstructured":"Karimi M, Haghpanah S, Bagheri MH, Bordbar MR, Pishdad P, Rachmilewitz EA (2012) Frequency and distribution of asymptomatic brain lesions in patients with \u03b2-thalassemia intermedia. Ann Hematol 91(12):1833\u20138","journal-title":"Ann Hematol"},{"issue":"1","key":"7251_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/nyas.13103","volume":"1375","author":"S Raz","year":"2016","unstructured":"Raz S, Koren A, Dan O, Levin C (2016) Cognitive functions in adults with \u03b2-thalassemia major: before and after blood transfusion and comparison with healthy controls. Ann N Y Acad Sci 1375(1):19\u201327","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"7251_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/bjh.15959","volume":"186","author":"I Tartaglione","year":"2019","unstructured":"Tartaglione I, Manara R, Caiazza M et al (2019) Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature. Br J Haematol 186(4):592\u2013607","journal-title":"Br J Haematol"},{"issue":"10","key":"7251_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/10245332.2017.1338212","volume":"22","author":"RHA MSE","year":"2017","unstructured":"MSE RHA (2017) Neurocognitive dysfunction in children with \u03b2 thalassemia major: psychometric, neurophysiologic and radiologic evaluation. Hematology 22(10):617\u2013622","journal-title":"Hematology"},{"issue":"8","key":"7251_CR13","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1016\/S2352-3026(23)00096-0","volume":"10","author":"FB Piel","year":"2023","unstructured":"Piel FB, Rees DC, DeBaun MR et al (2023) Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission. Lancet Haematol 10(8):e633\u2013e686","journal-title":"Lancet Haematol"},{"issue":"7","key":"7251_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00702-017-1710-2","volume":"124","author":"T Takamura","year":"2017","unstructured":"Takamura T, Hanakawa T (2017) Clinical utility of resting-state functional connectivity magnetic resonance imaging for mood and cognitive disorders. J Neural Transm (Vienna) 124(7):821\u2013839","journal-title":"J Neural Transm (Vienna)"},{"issue":"10","key":"7251_CR15","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00234-024-03414-y","volume":"66","author":"B Gen\u00e7","year":"2024","unstructured":"Gen\u00e7 B, Aslan K, Atay MH, Akan H (2024) Evaluation of microstructural changes in the brain in transfusion dependent thalassemia patients with advanced magnetic resonance imaging techniques. Neuroradiology 66(10):1721\u20131728","journal-title":"Neuroradiology"},{"key":"7251_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bcmd.2019.05.001","volume":"78","author":"AG Russo","year":"2019","unstructured":"Russo AG, Ponticorvo S, Tartaglione I et al (2019) No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses. Blood Cells Mol Dis 78:9\u201313","journal-title":"Blood Cells Mol Dis"},{"key":"7251_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nicl.2017.07.014","volume":"16","author":"N Egorova","year":"2017","unstructured":"Egorova N, Veldsman M, Cumming T, Brodtmann A (2017) Fractional amplitude of low-frequency fluctuations (fALFF) in post-stroke depression. Neuroimage Clin 16:116\u2013124","journal-title":"Neuroimage Clin"},{"issue":"8","key":"7251_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.euroneuro.2010.03.008","volume":"20","author":"MP van den Heuvel","year":"2010","unstructured":"van den Heuvel MP, Hulshoff Pol HE (2010) Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 20(8):519\u2013534","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"7251_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3174\/ajnr.A3849","volume":"35","author":"D Qiu","year":"2014","unstructured":"Qiu D, Chan GC, Chu J et al (2014) MR quantitative susceptibility imaging for the evaluation of iron loading in the brains of patients with \u03b2-thalassemia major. AJNR Am J Neuroradiol 35(6):1085\u20131090","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"7251_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-024-01638-x","volume":"17","author":"Y Gao","year":"2025","unstructured":"Gao Y, Liang C, Zhang Q et al (2025) Brain iron deposition and cognitive decline in patients with cerebral small vessel disease: a quantitative susceptibility mapping study. Alzheimers Res Ther 17(1):17","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"7251_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40279-013-0119-9","volume":"44","author":"SX Koh","year":"2014","unstructured":"Koh SX, Lee JK (2014) S100B as a marker for brain damage and blood-brain barrier disruption following exercise. Sports Med 44(3):369\u2013385","journal-title":"Sports Med"},{"issue":"3","key":"7251_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.STR.25.3.558","volume":"25","author":"H Schaarschmidt","year":"1994","unstructured":"Schaarschmidt H, Prange HW, Reiber H (1994) Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 25(3):558\u201365","journal-title":"Stroke"},{"issue":"6","key":"7251_CR23","doi-asserted-by":"publisher","first-page":"E144","DOI":"10.1002\/ajh.25787","volume":"95","author":"S Choi","year":"2020","unstructured":"Choi S, Leahy RM, Wood JC (2020) Lower white matter volume in beta-thalassemia associated with anemia and cognitive performance. Am J Hematol 95(6):E144\u2013E146","journal-title":"Am J Hematol"},{"issue":"3","key":"7251_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajh.20798","volume":"82","author":"O Nevruz","year":"2007","unstructured":"Nevruz O, Ulas U, Cetin T, Kutukcu Y, Kurekci A (2007) Cognitive dysfunction in beta-thalassemia minor. Am J Hematol 82(3):203\u2013207","journal-title":"Am J Hematol"},{"issue":"1","key":"7251_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60459-y","volume":"14","author":"N Pholngam","year":"2024","unstructured":"Pholngam N, Jamrus P, Viwatpinyo K et al (2024) Cognitive impairment and hippocampal neuronal damage in \u03b2-thalassaemia mice. Sci Rep 14(1):10054","journal-title":"Sci Rep"},{"key":"7251_CR26","doi-asserted-by":"publisher","first-page":"204062072311670","DOI":"10.1177\/20406207231167050","volume":"14","author":"M Bu","year":"2023","unstructured":"Bu M, Deng X, Zhang Y, Chen SW, Jiang M, Chen BT (2023) Brain iron content and cognitive function in patients with \u03b2-thalassemia. Ther Adv Hematol 14:20406207231167050","journal-title":"Ther Adv Hematol"},{"key":"7251_CR27","unstructured":"Qi L, Wuni W Study on the relationship between T2~* in brain tissue and iron overload in children with severe \u03b2-thalassemia and its pathogenesis. Mod Hosp 2019 19(01):70\u201373 ((in Chinese))"},{"issue":"3","key":"7251_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00062-011-0108-z","volume":"22","author":"S Akhlaghpoor","year":"2012","unstructured":"Akhlaghpoor S, Ghahari A, Morteza A, Khalilzadeh O, Shakourirad A, Alinaghizadeh MR (2012) Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of \u03b2-thalassemia patients. Clin Neuroradiol 22(3):211\u20137","journal-title":"Clin Neuroradiol"},{"issue":"881","key":"7251_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1259\/bjr.74.881.740407","volume":"74","author":"Z Metafratzi","year":"2001","unstructured":"Metafratzi Z, Argyropoulou MI, Kiortsis DN, Tsampoulas C, Chaliassos N, Efremidis SC (2001) T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major. Br J Radiol 74(881):407\u2013410","journal-title":"Br J Radiol"},{"key":"7251_CR30","doi-asserted-by":"publisher","first-page":"102058","DOI":"10.1016\/j.nicl.2019.102058","volume":"24","author":"R Manara","year":"2019","unstructured":"Manara R, Ponticorvo S, Tartaglione I et al (2019) Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study. Neuroimage Clin 24:102058","journal-title":"Neuroimage Clin"},{"issue":"4","key":"7251_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1971400917697342","volume":"30","author":"KA Smitha","year":"2017","unstructured":"Smitha KA, Akhil Raja K, Arun KM et al (2017) Resting state fMRI: A review on methods in resting state connectivity analysis and resting state networks. Neuroradiol J 30(4):305\u2013317","journal-title":"Neuroradiol J"},{"issue":"1","key":"7251_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12888-018-1992-4","volume":"19","author":"P Wang","year":"2019","unstructured":"Wang P, Yang J, Yin Z et al (2019) Amplitude of low-frequency fluctuation (ALFF) may be associated with cognitive impairment in schizophrenia: a correlation study. BMC Psychiatry 19(1):30","journal-title":"BMC Psychiatry"},{"key":"7251_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neulet.2018.11.007","volume":"692","author":"L Fan","year":"2019","unstructured":"Fan L, Hu J, Ma W, Wang D, Yao Q, Shi J (2019) Altered baseline activity and connectivity associated with cognitive impairment following acute cerebellar infarction: A resting-state fMRI study. Neurosci Lett 692:199\u2013203","journal-title":"Neurosci Lett"},{"issue":"3","key":"7251_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1034\/j.1600-0404.2000.102003162.x","volume":"102","author":"R Monastero","year":"2000","unstructured":"Monastero R, Monastero G, Ciaccio C, Padovani A, Camarda R (2000) Cognitive deficits in beta-thalassemia major. Acta Neurol Scand 102(3):162\u2013168","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"7251_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/bjh.15956","volume":"186","author":"D Rund","year":"2019","unstructured":"Rund D (2019) Cognition in thalassaemia: the next milestone. Br J Haematol 186(4):511\u2013512","journal-title":"Br J Haematol"},{"issue":"4","key":"7251_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1442-200X.2010.03279.x","volume":"53","author":"O Duman","year":"2011","unstructured":"Duman O, Arayici S, Fettahoglu C et al (2011) Neurocognitive function in patients with \u03b2-thalassemia major. Pediatr Int 53(4):519\u2013523","journal-title":"Pediatr Int"},{"issue":"5","key":"7251_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2217\/nmt-2018-0018","volume":"8","author":"AJ Larner","year":"2018","unstructured":"Larner AJ (2018) Mini-Mental State Examination: diagnostic test accuracy study in primary care referrals. Neurodegener Dis Manag 8(5):301\u2013305","journal-title":"Neurodegener Dis Manag"},{"issue":"4","key":"7251_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0883073814550827","volume":"30","author":"N Raafat","year":"2015","unstructured":"Raafat N, El Safy U, Khater N et al (2015) Assessment of cognitive function in children with beta-thalassemia major: a cross-sectional study. J Child Neurol 30(4):417\u201322","journal-title":"J Child Neurol"},{"issue":"3","key":"7251_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3889\/oamjms.2019.077","volume":"7","author":"IR El-Alameey","year":"2019","unstructured":"El-Alameey IR, Alzaree F, Shehata MA, Shady M, Atti MA, El-Khonezy MI (2019) Neurocognitive Function and Its Related Potentials in Children with Beta Thalassemia Major: An Egyptian Study. Open Access Maced J Med Sci 7(3):322\u2013328","journal-title":"Open Access Maced J Med Sci"},{"key":"7251_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2019.12.011","volume":"156","author":"S Bagwe-Parab","year":"2020","unstructured":"Bagwe-Parab S, Kaur G (2020) Molecular targets and therapeutic interventions for iron induced neurodegeneration. Brain Res Bull 156:1\u20139","journal-title":"Brain Res Bull"},{"issue":"2","key":"7251_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000522655","volume":"51","author":"P Limpawattana","year":"2022","unstructured":"Limpawattana P, Juntararuangtong T, Teawtrakul N et al (2022) Cognitive Impairment in Thalassemia and Associated Factors. Dement Geriatr Cogn Disord 51(2):128\u2013134","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"7251_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84395-z","volume":"15","author":"P Jamrus","year":"2025","unstructured":"Jamrus P, Pholngam N, Kiatpakdee B et al (2025) Iron induces blood-brain barrier alteration contributing to cognitive impairment in \u03b2-thalassaemia mice. Sci Rep 15(1):533","journal-title":"Sci Rep"},{"issue":"2","key":"7251_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/bpa.12920","volume":"31","author":"I Wimmer","year":"2021","unstructured":"Wimmer I, Scharler C, Kadowaki T et al (2021) Iron accumulation in the choroid plexus, ependymal cells and CNS parenchyma in a rat strain with low-grade haemolysis of fragile macrocytic red blood cells. Brain Pathol 31(2):333\u2013345","journal-title":"Brain Pathol"},{"issue":"Suppl","key":"7251_CR44","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1002\/ana.410320710","volume":"32","author":"JR Connor","year":"1992","unstructured":"Connor JR, Benkovic SA (1992) Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann Neurol 32(Suppl):S51-61","journal-title":"Ann Neurol"},{"issue":"2","key":"7251_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.10.006","volume":"133","author":"W Zheng","year":"2012","unstructured":"Zheng W, Monnot AD (2012) Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol Ther 133(2):177\u2013188","journal-title":"Pharmacol Ther"},{"key":"7251_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fncel.2012.00025","volume":"6","author":"SD Mesquita","year":"2012","unstructured":"Mesquita SD, Ferreira AC, Sousa JC et al (2012) Modulation of iron metabolism in aging and in Alzheimer\u2019s disease: relevance of the choroid plexus. Front Cell Neurosci 6:25","journal-title":"Front Cell Neurosci"},{"key":"7251_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.mri.2019.05.022","volume":"61","author":"P Yatmark","year":"2019","unstructured":"Yatmark P, Huaijantug S, Teerapan W, Svasti S, Fucharoen S, Morales NP (2019) MRI imaging and histopathological study of brain iron overload of \u03b2-thalassemic mice. Magn Reson Imaging 61:267\u2013272","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"7251_CR48","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.neuroimage.2012.05.049","volume":"62","author":"C Langkammer","year":"2012","unstructured":"Langkammer C, Schweser F, Krebs N et al (2012) Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 62(3):1593\u20131599","journal-title":"NeuroImage"},{"key":"7251_CR49","unstructured":"Guan JJ, Feng YQ (2018) [Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping]. Nan Fang Yi Ke Da Xue Xue Bao. 38(3):305\u2013311"},{"issue":"2","key":"7251_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/0028-3886.284377","volume":"68","author":"P Saikiran","year":"2020","unstructured":"Saikiran P, Priyanka (2020) Effectiveness of QSM over R2* in assessment of parkinson\u2019s disease - A systematic review. Neurol India 68(2):278\u2013281","journal-title":"Neurol India"},{"issue":"2","key":"7251_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/18756190MTA44NjEs3","volume":"19","author":"U Langeh","year":"2021","unstructured":"Langeh U, Singh S (2021) Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders. Curr Neuropharmacol 19(2):265\u2013277","journal-title":"Curr Neuropharmacol"},{"key":"7251_CR52","unstructured":"Serum levels of S100B and NSE proteins in Alzheimer\u2019s disease patients"},{"issue":"15","key":"7251_CR53","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2174\/0929867323666160406121117","volume":"23","author":"ZZ Chong","year":"2016","unstructured":"Chong ZZ, Changyaleket B, Xu H, Dull RO, Schwartz DE (2016) Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases. Curr Med Chem 23(15):1571\u20131596","journal-title":"Curr Med Chem"},{"issue":"12","key":"7251_CR54","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.3390\/ijms18122724","volume":"18","author":"A Kanavaki","year":"2017","unstructured":"Kanavaki A, Spengos K, Moraki M et al (2017) Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy. Int J Mol Sci 18(12):2724","journal-title":"Int J Mol Sci"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07251-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:02:44Z","timestamp":1792692164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07251-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7251"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07251-2","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Approval No. 2025-E0221). Written informed consent was obtained from all participants in accordance with the Declaration of Helsinki. Animal procedures were approved by the Animal Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Approval No. 2025-D0311).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have agreed to publish.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"477"}}